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Abstract 
With the increasing use of nanomaterials (NMs) in a variety of commercial and medical 
applications, there is a parallel increase in concern related to unintentional exposure. This 
leads to a pressing need for appropriate hazard and risk assessment, and subsequent 
regulation of these new and emerging nanosubstances. Typically, in vitro models are the first 
point for assessment, and these are often then used to begin to predict and translate the 
potential effects in vivo. The area of nanotoxicology is therefore critically important, and 
requires that experimental protocols are clear, defined and standardized within adequate risk 
assessment frameworks to allow hazard identification and extrapolation to more realistic in 
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vivo situations. Often, however, results seen in vitro do not adequately represent the 
situation in vivo. There are many differences between in vitro and in vivo investigations; 
however one issue may arise from the way in which typical nanosafety studies are carried 
out. Nanotoxicity assessment requires a definition of dose and standardized modes of 
exposure in nanomaterial uptake and cytotoxicity studies to determine the hazard that is 
posed by naturally occurring and engineered (E-)NM. Current methods in nanotoxicity 
studies often report only the exposure dose, which can lead to large variations in the intrinsic 
or delivered dose due to inhomogeneous exposure and loss of treatment material depending 
on how NMs are “presented” to cells.  Protocols for Nanomaterial (NM) dispersion and 
cellular assay design therefore require Standard Operation Procedures (SOPs). Many 
experimental conditions in NM studies directly affect the NM behaviour within the cell 
culture system, in particular handling of NM dispersions as well as the order, timing and 
exposure configurations of the incubation; these can have an immediate effect on the 
resulting physical distribution of NMs on the cell surfaces.  Here we review handling, physical 
conditions and particle distribution in cell models for NM exposure to cells and tissues.  
Efforts to improve in vitro models such that they more closely mimic the in vivo conditions, 
such as exposure mechanism and dose, and potential for transport of nanomaterials across 
cells are being developed rapidly, driven partially by the strong push within the EU to reduce 
animal testing.  Examples include the use of multiple in vitro assays to calculate hazard, air-
liquid interface (ALI) exposure, microfluidic approaches and 3D co-culture models. 
 
Keywords 
Nanosafety, nanomaterials, reproducibility, dosimetry, presentation mode, 3 dimensional cell 
culture, organoids, receptor mediated endocytosis, diffusion, sedimentation 
 
List of abbreviations: 
3D- 3-dimensional; ALI – air-liquid interface; BBB – blood brain barrier; BSA – bovine serum 
albumin; DCS - Differential Centrifugal Sedimentation; DLS - dynamic light scattering; DSE – 
delivered sonication energy; DLVO – Derjaguin, Landau, Ververy and Overbeek theory; (E-
)NM – engineered nanomaterial; FAE - follicle-associated epithelium; FBS - foetal bovine 
serum; GI - gastrointestinal; IATA - Integrated Approaches to Testing and Assessment; ISDD - 
In vitro Sedimentation, Diffusion and Dosimetry model LM – Light Microscopy; MWCNT - 
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multi-walled carbon nanotubes; NM – nanomaterial; OECD – Organisation for Economic 
Cooperation and Development; PDE - partial differential equation; PCTS - precision cut tissue 
slices; QD - quantum dot; REACH – Registration, Evaluation and Authorisation of Chemicals; 
ROS – reactive oxygen species; SOP - standard operating procedure; spICP-MS – single 
particle Inductively coupled mass spectrometry; TEM – transmission electron microscopy; 
TfR - transferrin receptor.   
 
Introduction 
Exposure to naturally formed nanomaterials (NMs) can occur through processes such as 
weathering, erosions, and volcanic eruptions. NMs can also be an integral part of natural bio-
logical processes such as the sensing of the earth’s magnetic field by bacteria (Loehr et al., 
2016). However, the past decade has seen an unparalleled increase in the range and quantity 
of NMs produced commercially for use within a host of applications ranging from electronics, 
remediation, food additives and biomedical imaging and therapy. Therefore it is a critical pri-
ority that appropriate toxicological studies are performed to ascertain the potential short 
and long term risk posed by these emerging engineered (E-)NMs. Proper risk assessment is 
therefore necessary to ensure the safe use of these agents within the range of applications in 
order to avoid a repetition of catastrophic events in history that were seen with exposure to 
substances such as asbestos (Seaton et al., 2010). An important factor to achieving this goal 
is the ability to at least partially translate the effects seen in vitro to the potential for harm in 
vivo, as the expense of in vivo testing makes extensive testing of all potential NMs impossi-
ble. Indeed, it has been estimated that it will cost up to €600 million to register the 500 - 
2,000 NMs that are expected to be placed on the EU market at volumes of at least 1 
tonne/year under REACH and other legislations (e.g., for cosmetics), the vast majority of 
which is related to the need for 90-day inhalation and oral animal exposures (European 
Commission, 2013).  Thus, there is an urgent need for in vitro methods that are predictive of 
the in vivo outcomes observed, in order to reduce our reliance on animal testing.  This could 
comprise a battery of in vitro assays that should be performed to collectively inform on the 
(E-)NM potential for harm, or specific testing strategies incorporating 3D models or special-
ized exposure systems. It is important to note that these in vitro approaches that are dis-
cussed herein provide a means for addressing the hazard component of a risk assessment. 
Once suitable Standard Operating Procedures (SOPs) are developed for the hazard assess-
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ment of (E-)NMs, these can be incorporated into a risk assessment framework to appropri-
ately determine the potential for harm based on environmentally relevant expected expo-
sure levels.   
 
In vitro toxicity testing is therefore a fundamental part of any hazard identification strategy. 
An essential component of making these necessary toxicological studies reproducible and 
predictive of the in vivo situation is the availability of standardized assays to allow reliable 
determination of the toxic potential. A number of factors can determine the toxicity associ-
ated with a given NM; the actual uptake behaviour of NMs is one key parameter, and as such 
is a much studied area (Aillon et al., 2009; Alkilany and Murphy, 2010; Misra et al., 2012; 
Panariti, Miserocchi and Rivolta, 2012; Huk et al., 2014; Kettler et al., 2014; Shin, Song and 
Um, 2015). Therefore, the properties that determine toxicity are often determinants in the 
amount and mechanism of cellular entry of the specific NMs and their eventual effects with-
in the cell population; this is discussed more in the section ‘cellular uptake of NMs’. Many 
current in vitro toxicity assays applied to NMs are therefore based upon NM exposure studies 
followed by determination of toxicity by end-points such as induction of reactive oxygen spe-
cies (ROS), lysosomal integrity or membrane permabilisation (Farcal et al., 2015). 
 
There are a number of variables that can lead to differences or inaccuracies during these in 
vitro procedures that arise both from the experimental in vitro system used and the NM sus-
pensions themselves, which will be introduced in the subsequent sections.  For example, 
standard toxicity assays were generally designed for use with chemical compounds or mole-
cules, therefore they may well not be appropriate for assessment of NM toxicity – some NM 
have even been seen to bind to standard dyes used in these types of assays (Ong et al., 
2014). Furthermore, NMs present in suspension and/or bound at the cell surface can also 
interfere directly with the read out by altering the light absorbance or scatter due to their 
optical properties (Bahadar et al., 2016). Various interferences have been reported between 
NMs and standard toxicity assays which can confound toxicity assessment results (Kroll et al., 
2009). Minimising these types of interferences is therefore critical for successful in vitro as-
says, and often relies on the determination of appropriate control experiments to perform 
alongside (Rosslein et al., 2015).  Even when performed alongside appropriate controls, a 
single assay can often not give enough information regarding the toxic potential of some 
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NMs. There has therefore been a significant push to find assays or combinations of assays 
that can better reflect the in vivo hazard posed by NMs with some success (Wiemann et al., 
2016). The macrophage assay, whereby alveolar macrophages are treated with numerous 
different NMs, involves the subsequent measurement of multiple endpoints that can then be 
used to determine the active or passive nature of NMs; the assay prediction models proved 
easy to use, and highly efficient for predicting in vivo hazard potential of NMs (Wiemann et 
al., 2016). Similar multi-endpoint principles were applied in the high throughput screening of 
NMs using microscopical examination as part of the FP7 NanoMILE project (Hansjosten et al., 
2017).  In these examinations multiple endpoints were assessed and then NMs were scored 
based on the result severity, giving a multi-parametric approach to advise on the various 
hazards associated with cellular exposure to a variety of NMs (Hansjosten et al., 2017). In-
deed, the integration of data types from several testing strategies (old or new) toward NM 
hazard characterization is the basis of the OECD Integrated Approaches to Testing and As-
sessment (IATA), although regulatory acceptance of newly emerging approaches lags consid-
erably behind their development (Sewell et al., 2017). 
 
As the field of nanotoxicology progresses there is an increasing demand for a higher level of 
reliability and quantification of the assays currently performed. Recently, Rosslein et al. de-
scribed the use of cause and effect analysis of assay systems to determine sources of variabil-
ity within tested methods. This was aimed at establishing the necessary controls in order to 
increase the validity of in vitro results (Rosslein et al., 2015). This cause and effect method 
allows for the use of controls that can account for some of these unwanted interactions and 
effects, such as NM interference and NM binding to assay components (Ong et al., 2014; 
Guadagnini et al., 2015; Rosslein et al., 2015). Methods such as these are very important for 
developing SOPs, and can be used to greatly enhance the reliability of the data, accounting 
for the large number of variables present including cell seeding and instrument interference.  
Where experiments do not reflect similar results, increased recording of crucial metadata 
surrounding experimental conditions from plating to end-point determination will undoubt-
edly play an important role. This metadata might also indicate critical factors that determine 
reproducibility, and as such should be specified in future versions of protocols. Recording of 
these steps, along with information on NM storage conditions and age/provenance, will likely 
minimize the variability between different studies performed at separate points in time and 
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locations and thus increase the reliability of the data available (Sarathy et al., 2008; 
Kuchibhatla et al., 2012; Izak-Nau et al., 2015; Baer, Munusamy and Thrall, 2016).  Sample 
ageing during storage also plays an important role, and indeed the same NMs tested 6 
months apart for their effects on A549 (Adenocarcinomic human alveolar basal epithelial ) 
cells resulted in significantly different toxicity, even when the NM stock solutions were stored 
under “optimal” conditions – i.e., at 4 °C in darkness (Izak-Nau et al., 2015).  Thus, NM ‘aging’ 
effects can be a significant contributor to the contradictory toxicity results observed in the 
literature for identical NMs, and NM ageing should be assessed in parallel with toxicity as-
sessment as best practice. 
 
Despite the advances in terms of assay reliability and availability, often the performed in vitro 
studies give rise to conflicting information and poorly reflect the situation in vivo. It is likely 
that inappropriate NM dispersion, poor characterisation of the NMs dispersions over the ex-
posure duration, incomplete reporting and use of incorrect exposure metrics in in vitro stud-
ies play a largely ignored role in the poor in vitro-in vivo correlations to date (Hinderliter et 
al., 2010; Dawson et al., 2013).  One fundamental principle in toxicology is the “dose-
response” whereby the effect of a molecule is directly proportional to the dose at the specif-
ic target site. However, the dose-response is not always linear for NMs – higher doses can 
lead to agglomeration, via weak interacting forces between NMs, and thus less available 
dose and lower toxicity (Baalousha, 2009; Hussain et al., 2009; Mudunkotuwa and Grassian, 
2011; Bell, Ives and Jonas, 2014). It is important here to distinguish between reversible NM 
agglomeration, and the stronger irreversible formation of aggregates, as the two terms are 
often, incorrectly, used interchangeably (Sokolov et al., 2015). Another important aspect is 
the way in which the dose is quantified and reported. There is no official or standard defini-
tion of NM dose as of yet, and often it is recommended that multiple doses are reported in-
cluding mass, number and surface area concentration (Drasler et al., 2017). Often the dose is 
given as the mass of NM per area cell culture in µg/cm2. Sometimes the dose is only indirect-
ly defined by specification of the NM concentration in µg/mL administered to the cell cul-
ture. The implications of dosimetry and particokinetics on the interpretation of response was 
first highlighted by Teeguarden et al, and has since been the subject of comprehensive re-
views (Teeguarden et al., 2007a; Park et al., 2009; Drasler et al., 2017). The measure of the 
dose at a specific site will depend largely on the experimental conditions and therefore these 
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effects must be accounted for to ensure accuracy of the reported results. The cellular NM 
dose is often assumed to be estimated by, or proportional to, the concentration of NM in the 
treatment media in in vitro studies – a situation that is unlikely to be the case for numerous 
reasons, including NM agglomeration, loss to vessel walls (Figure 1), and the fact that the 
uptake of NMs is generally receptor mediated such that only a proportion of the available 
NMs can be internalised at any moment in time (Figure 2).  Work on single particle identifica-
tion and tracking of NM uptake renders the most obvious definition of NM dose as the num-
ber of NM per cell (either internalized or tightly bound) (Drasler et al., 2017). This can be re-
ferred to as the “local dose” or “cellular dose”, in contrast to the quantity of the administered 
material which can be thought of as the “Administered dose” (Richitor et al., 2016).   
 
Differences between the administered and local cellular dose can arise through a variety of 
means, including, but not limited to, alterations in size distributions due to agglomeration, 
changes in total NM number due to loss of material (e.g. for NMs that undergo dissolution), 
transport of the NM through the medium and inhomogeneous distribution. Here, the admin-
istered dose is discussed in terms of its relation to the local (cellular) dose by evaluating the 
evolution, transport and distribution of NMs during preparation and cellular exposure. With-
in this context, this review evaluates methods for performing NM uptake experiments and 
reports on the distribution of NMs over a cell population from the different approaches. 
There are a variety of modes available for NM presentation to cells (see Figure 3) and with 
correct reporting and performing of the experiments these can provide reproducible and ac-
curate comparisons between NM studies in adherent cell types in-vitro. The goal of the eval-
uation made here is therefore to formulate a recommendation for the standardized delivery 
of NMs to cultured cells and the minimum amount of information that should be reported. 
Indeed, within the EU-funded QualityNano research infrastructure, a central goal was the 
development and ring-testing of a number of SOPs for NMs physico-chemical characterisa-
tion and in vitro toxicological evaluation, including NM size characterisation by Dynamic Light 
Scattering (DLS) and Differential Centrifugal Sedimentation (DCS), quantification of cellular 
uptake of NMs by flow cytometry and cytotoxicity determined by the MTS assay, which in-
cluded detailed descriptions of cell culture processes and the dispersion of the NMs in the 
appropriate cell culture medium. These protocols, and the ring-tests or interlaboratory com-
parisons undertaken on them, are described in detail in articles included in this special issue 
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(Langevin et al. 2017; Salvati et al. 2017).   
NM dispersions and agglomeration 
Prior to in vitro toxicity studies, NMs must first be dispersed in aqueous media. We have 
shown that, without detailed instructions for sample preparation and measurement, even for 
simple measurement of NM dispersions in water, high variability in size and size distribution 
can be generated (Langevin et al., 2017). For this reason there has been a large focus on ob-
taining SOPs for repeatable dispersion methods using inter and intra-lab comparisons, devel-
oped as part of EU Framework Programme (FP6 and FP7) funded projects (Farcal et al., 
2015).  Obtaining a reproducible and homogenous dispersion in the complex biological fluids 
used for in vitro testing poses further challenges that have been addressed as part of the 
NanoGenoTox project, where an SOP was developed for the dispersion of hydrophobic NM 
powders such as TiO2 and ZnO by using an ethanol pre-wetting stage, followed by dispersion 
in 0.05% BSA water and subsequent sonication and dispersion in cell culture medium (Al-
strup Jensen et al., 2011; Farcal et al., 2015). The method of NM dispersion and the physio-
chemical properties of the dispersion can greatly affect the resulting outcomes in biological 
testing. Successful NM dispersion can be thought of as uniform, reproducible each time the 
process is applied (i.e. the same material dispersed the same way gives the same size and 
polydispersity index), stable over the duration of the test or characterised at the beginning 
and end of the exposure, and preferably consisting chiefly of primary particles with minimum 
size and minimum agglomeration.  Unstable suspensions may have larger size distributions 
(more polydisperse), and altered agglomeration state (weak bonds between particles) and/or 
aggregation (harder to break bonds between particles) and tend to be less reproducible from 
one dispersion to another. This can lead to changes in the properties of the dispersion, and 
can therefore modulate processes such as cellular uptake. Larger particles are generally in-
ternalised less than smaller particles by receptor mediated processes and/or are internalised 
via different pathways (e.g. macropinocytosis rather than clathrin or caveolin mediated en-
docytosis) (Doherty and McMahon, 2009; Sahay, Alakhova and Kabanov, 2010; Zaki and 
Tirelli, 2010; Kou et al., 2013; Kafshgari, Harding and Voelcker, 2015). Thus, the size and ag-
glomeration state are important parameters when determining the potential toxicity of the 
material. NM dispersions will always show a certain level of polydispersity (typically between 
0.1 and 0.4 is considered moderately polydisperse, with values >0.4 being very polydisperse, 
although it should be noted that different synthesis routes can produce different polydisper-
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sities for the same NM), which can vary with material, solvent and synthesis method used, as 
well as with the stabilisation mechanism, e.g. sterically stabilised with polymer coatings ver-
sus electrostatically stabilised with small charged molecules such as citrate. However some 
NM preparations will show increased polydispersity due to agglomeration and inter-particle 
interactions, especially in media with high ionic strengths which can overcome electrostatic 
stabilisation.  Much effort has therefore been focussed on studying the colloidal forces gov-
erning NM deposition and aggregation (Weitz and Lin, 1986; Petosa et al., 2010).  There are 
various methods that can be employed to reduce agglomeration effects during dispersion 
protocols, including ultrasound, milling and magnetic fields (Bihari et al., 2008; Stuyven et al., 
2009; Vippola et al., 2009).  Derjaguin, Landau, Ververy and Overbeek (DLVO) theory of col-
loidal stability describes the agglomeration of aqueous dispersions and the active forces in-
volved such as van der Waals forces and repulsion. Together with the interactions considered 
in the DLVO theory, forces such as steric interactions, magnetic forces (for iron-based NMs), 
and hydration forces influence the stability of NMs in aqueous media (Petosa et al., 2010). 
Aggregation dynamics have also been found to be dependent on the amount and type of 
NMs (Weitz and Lin, 1986).   
 
Several quantitative and qualitative studies have been performed to investigate NM aggrega-
tion, in addition to studies aimed at determining the most effective dispersion methods 
(Sano and Okamura, 2001; Anderson and Barron, 2005; K. L. Chen, 2006; Bihari et al., 2008; 
Saleh, Pfefferle and Elimelech, 2008; Vippola et al., 2009; Domingos, Tufenkji and Wilkinson, 
2009; Fang et al., 2009; Jiang, Oberdörster and Biswas, 2009; Bouwmeester et al., 2011; 
Lamberty et al., 2011; Ramirez-Garcia et al., 2011; Mejia et al., 2012). Sonication followed by 
the addition of dispersion stabilizers, such as Bovine serum albumin (BSA), serum or phos-
pholipids has previously been determined as successful, and standardized methodologies 
describing this are therefore available (Bihari et al., 2008; Alstrup Jensen et al., 2011). An im-
portant factor that has been highlighted is the calibration of the Delivered Sonication Energy 
(DSE), both in terms of the energy delivered, and the material-specific critical DSE (crDSE) 
energy required to achieve stable suspensions with minimal aggregate size (DeLoid et al., 
2017). 
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Agglomeration leads to a large NM size distribution (polydispersity) and results in changes to 
the suspension, such as modification of the number of NMs present and the surface area 
that is available (DeLoid et al., 2017). Different sized particles will also diffuse through liquids 
at different rates.  Larger NMs, agglomerates and aggregates arrive at the cell surface at a 
faster rate in traditional submerged culture than smaller NMs due to the role of sedimenta-
tion (which is proportional to the square of their diameter), as discussed in the next section 
and shown in Figure 4 (Hanarp et al., 2001).  Agglomeration effects can be more pronounced 
when NMs are dispersed in protein rich cell medium at physiological pH and salt concentra-
tions, due to protein corona formation which, depending on the NMs and the surrounding 
conditions, can lead to stabilisation or destabilisation of NMs dispersions (Monopoli et al., 
2012; Lynch et al., 2013; Nasser and Lynch, 2016). Crist et al, highlighted the importance of 
performing characterizations in the appropriate media due to these changes that occur to 
the NMs properties (Crist et al., 2013). They also highlighted the problems associated with 
using a single method of size characterization. For example, when examining Transmission 
Electron Microscopy (TEM) measurements of size, pre and post dispersion in cell media, the 
measured size remains the same (since TEM only measures the core electron dense particles 
not any surface adsorbed weakly scattering biomolecules), whereas when measured by DLS 
the size is nearly doubled as a result of biomolecule adsorption and hydration, indicating the 
necessity of multiple size measurements prior to in vitro toxicity studies (Crist et al., 2013).  
Our recommendation is to combine a method to measure the core particle size (e.g. TEM), 
and a method to indicate the hydrodynamic size (in the exposure medium) such as DLS or 
DCS which provides an effective size in protein-containing medium (Domingos et al., 2009; 
Dawson et al., 2013).   NM size distribution is most often measured immediately after NM 
exposure to cell medium. However, agglomeration is a time dependent process and the size 
distribution may change over the cell incubation period, and should therefore be monitored 
throughout the exposure duration (Shapero et al., 2011; Dawson et al., 2013). The NM size 
distribution at the cell surface will also differ from the size distribution in solution due to 
concentration effects.  Overall, it is now widely recognised that NM uptake and impact stud-
ies require a detailed characterisation of the stability and properties of the NM dispersion. 
Therefore efforts are being made to define the minimum set of information and conditions 
which should be provided prior to cellular exposure experiments, which we have attempted 
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to summarise at the end of this article (Bouwmeester et al., 2011; Roebben et al., 2011; Crist 
et al., 2013; Stefaniak et al., 2013; Sharma et al., 2014; DeLoid et al., 2017). 
 
The choice of metric - NM dosimetry 
There has been significant debate in the scientific literature as to the most relevant dose 
metric for NMs, with consensus that mass based doses are not relevant for NMs, while 
surface area and particle number seem more appropriate and more predictive of 
toxicological outcomes (Oberdörster, Oberdörster and Oberdörster, 2007; Wittmaack, 2007, 
2011; Lison et al., 2008; Rushton et al., 2010; Simkó, Nosske and Kreyling, 2014; Braakhuis et 
al., 2015; Schmid and Stoeger, 2016). Indeed, the same in vitro toxicity data for silver (Ag) 
NMs plotted by mass, surface area and particle number resulted in quite different outcomes. 
Results expressed in mass unit [μg/cm2] suggested that the toxicity of Ag NMs was size-
dependent, with 50 nm particles being most toxic to Chinese Hamster Lung (V79-4) cells. 
However, re-calculation of Ag NM concentrations from mass to surface area and number of 
NMs per cm2 highlighted that 200 nm Ag NMs were the most toxic (Huk et al 2014).  
Wittmaack highlighted the necessity of reporting the cellular accumulated dose in a study of 
SiO2 NMs, whereby the toxicity observed depended on the areal density of NM mass that is 
delivered to cells (Wittmaack, 2011). The importance of the dosimetry has led to the 
emergence of attempts to document and standardize the ways in which dosing is carried out 
and quantified, in the form of published protocols (DeLoid et al., 2017). These protocols 
cover the generation of stable NM suspensions in culture medium, characterization of these 
colloids and modelling of the local dose delivered to cells over time (Hinderliter et al., 2010; 
DeLoid et al., 2017). These protocols include transport models that accommodate variable 
binding kinetics (of NMs) to the culture dishes, simulation of polydisperse suspensions and 
dissolution of NM during deposition to determine dose metrics for in vitro studies using 
MATLAB (DeLoid et al., 2017). 
 
Particle dosimetry differs significantly from that of conventional chemicals, partly due to the 
dynamic nature of particle suspensions which can be governed and modified by the NM 
physicochemical characteristics themselves and the properties of the surrounding media. 
This in turn leads to changes in the suspension itself and to the dose received by target cells 
in in vitro assays over the exposure time-course. Different NMs diffuse at different rates 
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dependent upon their characteristics such as size, density, shape, surface charge and surface 
coating/functionalization, discussed in more detail in the section ‘Diffusion’. NMs can also 
agglomerate over time and acquire different surface constituents (charge neutralisation, 
corona evolution) which can also modify interactions with the surrounding fluid and cells. 
These evolving properties also lead to changes in sedimentation rates and therefore different 
amounts of NM reaching the target site, discussed later in the section ‘Sedimentation’. The 
fluid itself leads to changes in NM interactions and motion, depending on parameters such as 
viscosity, protein content, ionic strength and pH, which are discussed more in the sections 
‘Diffusion’ and ‘Sedimentation’.  Thus transport of NMs towards the cell surface can itself 
affects the NM distribution and cause formation of aggregates in in-vitro toxicity experiments 
as a function of time. The movement of NMs through a fluid is a combination of the 
sedimentation of the NMs and the diffusion of NMs over time, both of which are highly 
related to, and dependent upon, the agglomeration state and the dissolution potential in the 
media (see Figure 1).  Mason and Weaver derived a mathematical solution to this, termed 
the laminar convection diffusion equation, in the form of a partial differential equation (PDE) 
as shown in equation 1 (Mason and Weaver, 1924). The components of this, sedimentation 
and diffusion, are described subsequently: 
 
𝜕𝑛
𝜕𝑡
= 𝐷
𝜕2𝑛
𝜕𝑥2
− 𝑉
𝜕𝑛
𝜕𝑥
 
(Equation 1) 
 
 
where n is particle concentration, t is time, x is distance and D and V are the Diffusion and 
Sedimentation velocities, respectively. 
 
Sedimentation, or gravitational settling, is the tendency of particles to settle at the bottom 
of a container due to gravitation. This sedimentation rate, for single NMs, is a function of 
density of the medium, the density of the NMs in the medium, and diameter of the NM, and 
is described mathematically by Stokes’ law (eqation. 2) which determines the gravitational 
settling velocity, V (Kajihara, 1971):   
 
𝑉 =
𝑔(𝑃𝑁𝑝 − 𝑃𝑚)𝑑
2
18ŋ
 (Equation 2) 
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where the acceleration due to gravity is g, 𝑃𝑁𝑝and 𝑃𝑚are the mass density of the NMs and 
the medium respectively, 𝑑is the NM diameter and ŋis the cell culture medium dynamic 
velocity. 
 
The process of sedimentation is shown schematically in Figure 4, along with the dependence 
of sedimentation on NM diameter and media and NM densities.  Previously, variations of 
Stokes law, such as Sterling’s modification, have been used to describe the sedimentation 
velocity of NM agglomerates, which will differ compared to that of single particles, and to 
determine the agglomerate effective density (Sterling et al., 2005; Hinderliter et al., 2010; 
Mukherjee et al., 2014; Cui et al., 2016). Agglomeration and aggregation are complex 
processes that are affected by the diffusion of individual and associated particles, in addition 
to the attractive and repulsive forces present between NMs. Sterling’s modification for 
agglomerates incorporates properties of the agglomerates including their effective density, 
packing factor and fractal dimension, as agglomerates do not exist as homogenous units 
(Mukherjee et al., 2014). These are important considerations when modelling NM transport, 
and therefore must be included in any calculations performed to determine the effective 
dose at the cell surface. However, Sterling’s modification does not take into account the 
inter-particle forces, a factor that is incorporated into the previously mentioned DLVO theory 
(Petosa et al., 2010). Sterling modification provides an estimate of the effective agglomerate 
density, rendering it potentially inaccurate (DeLoid et al., 2014). DeLoid et al determined a 
simple method to measure the effective density by means of a Volumetric Centrifugation 
Method (VCM) (DeLoid et al., 2014). This method is based upon centrifugation of a sample at 
low speed in a packed cell volume tube, and measurements were found to agree with the 
more costly Analytical Ultracentrifugation (AUC) method (Carney et al., 2011; DeLoid et al., 
2014). Agglomerates are important in terms of sedimentation (and diffusion) as the 
sedimentation speed increases proportionally to the square of the particle diameter and is 
proportional to the difference between the medium density and the particle effective 
density (Cui et al., 2016). The agglomeration rate, and therefore sedimentation rate, can be 
modulated by changing the balance of attractive or repulsive forces between NMs, which can 
be achieved through surface modification, or by altering the properties of the media (pH, 
ionic strength, ionic composition) (Keller et al., 2010). Increasing the stability of NM 
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suspensions, either by electrostatic or steric stabilization, decreases the agglomeration rate. 
An example of this is the presence of proteins within the medium (such as BSA) which can 
stabilize NM suspensions, presumably due to steric stabilization, leading to a reduction in the 
agglomeration rate and therefore changing the sedimentation rate of the NMs (Allouni et al., 
2009). 
 
Agglomeration changes the size, shape and effective particle density thereby modulating 
transport time. The effective density of agglomerates will also vary considerably compared to 
that of the primary NM density, due to the inclusion of media within the agglomerate. As an 
example of why changes to NM density are important, buoyant NMs with low density 
compared to the media, can float and rise away from cells over time, rendering dose 
response relationships difficult or even impossible to ascertain (DeLoid et al., 2014; DeLoid et 
al., 2017). This clearly has an implication for study design, i.e. use of standard (submerged), 
or inverted cell culture systems (see Figure 3). If parameters such as NM size, effective 
density, viscosity of the medium, along with agglomeration potential are known, then the 
rate of gravitational settling can be calculated, along with the time that the NMs will likely 
take to reach the bottom of the container (or reach the cells at the bottom of a petri-dish). 
The shape of the NM will also lead to changes in drag and buoyancy forces acting upon the 
NM, thereby modifying the transport time, and is suggested to lead to an increased 
sedimentation under the exposure conditions. Shape will also affect the agglomeration and 
aggregation potential of the suspension, in addition to agglomeration affecting the particle 
‘shape’ (Alkilany and Murphy, 2010). However, it has been suggested that NMs with an 
aspect ratio of less than 2 can be adequately represented as spheres, while those that have 
an aspect ratio greater than 2 require alternative models (Herzhaft and Guazzelli, 1999; 
Teeguarden et al., 2007b; Swaminathan et al., 2012). The effect of shape on sedimentation 
has been reported to be very different between static and dynamic systems under flow, 
which is an important consideration for in vivo translation since most in vitro models are 
static (Bjo et al., 2016) However, perfusion approaches are available and are typically used to 
mimic interaction of NMs with blood vessels (Tian and Finehout, 2008; Prabhakarpandian et 
al., 2011; Albanese et al., 2013; Rennert et al., 2015; Bjo et al., 2016).  As represented in the 
schematic illustrations in Figures 1, 4, 5 and 6, other parameters will also influence the rate 
of transport such as the height of the container which has an impact on the time that a NM 
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will take to settle, as does the material and shape of the container, discussed later in the 
section ‘role of media height and container’. 
Diffusion is a transport phenomenon that occurs due to the gradient of concentration and is 
represented by the first term in Equation 1. In the absence of sedimentation Equation 1 
reduces to Fick’s second law, which describes the concentration changes that occur over time 
due to diffusion.  Starting from a well-mixed solution with constant concentration we expect 
no net particle transport. However, the concentration of NMs at the boundaries will often 
change with time – such as during cellular exposure where NM’s will be removed due to 
internalization thus creating a concentration gradient. As a result there will be a diffusive 
transport of NMs towards the adsorbing surface. The typical transport length that a 
nanoparticle diffuses over time is given by the mean squared displacement 
 
⟨𝑥2⟩ = 2𝐷𝑡 (Equation 3) 
 
where D is the diffusion coefficient and t is time. 
 
Since the diffusion coefficient for spherical NMs is related to the NM size according to the 
Stokes-Einstein equation, NM diffusion rates are a function of NM size and viscosity of the 
medium (effective particle density) (equation 4).  The Stokes-Einstein equation describes the 
relationship between the rate of diffusion (D, m2/s) as a function of viscosity (ŋ and 
temperature (T, oK): 
 
𝐷 =
𝑘𝑏𝑇
6𝜋ŋ𝑑
 (Equation 4) 
 
where R is the gas constant (L kPa/K/mol), kb iis the boltzmann constany, and d the NM 
diameter. 
 
The diffusion coefficient is inversely proportional to NM size; hence smaller particles diffuse 
more rapidly than larger ones. Diffusion is therefore the dominant force governing delivery 
of small NM to cells in vitro. Larger particles (or agglomerates/aggregates) are transported 
more through sedimentation forces (Cohen 2015). Nevertheless, the motion of NMs in fluid 
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media, as well as the transport of macromolecules and colloidal particles, can be governed 
partly by diffusion forces. The Brownian motion in NM dispersions gives them high mobility, 
but also an increase in the probability for collision that can lead to surface interactions and to 
the formation of agglomerates leading to destabilisation of the suspension. These 
agglomerates, as previously mentioned, can have very different properties that modify the 
diffusion rate, such as decreased effective density and decreased surface area to mass ratio 
(as the structures are not being fully solid due to entrapped liquid between the NMs), 
increased volume, and different shapes.  Likewise, dissolution of NMs will change the size 
distribution of the suspension; smaller NMs will dissolve at an increased rate, therefore 
changing the concentration and size distribution of the suspension. Sedimentation and 
diffusion processes are both a function of medium density and viscosity, and are dependent 
on NM size, shape, charge, and/or density of the NMs. These phenomena can therefore be 
competitive or act together on NM transport, and can affect the time that NMs require to 
come into contact with cells in the dish, and thus to become active at the cell surface. 
 
Role of the exposure time 
Toxicity experiments are typically performed over 24-48 h, but the NM diameter and density 
can radically change the time a particle requires to reach the cell surface. Indeed it is 
reported that the time taken for 90% of a NM dose to be deposited can vary between <10 
hours to >200 hours depending on the NM in question, which clearly has big implications for 
the delivered local dose (Cohen, Teeguarden and Demokritou, 2014). This can alter the 
number of NMs truly interacting with the cells during the exposure time.  Figure 4 shows 
how particles cross dissimilar distances at a particular time of exposure. For example, while 
PS NMs less than 3 nm in diameter might be able to travel 5 mm in 24 h, 100 nm PS NMs 
would require much longer to travel the same distance. If only a few NMs are able to reach 
the target cell in this time, uptake may be reduced and consequently the true “internalised 
dose” will also be reduced.  An example that can illustrate these problems is that of a NM 
that agglomerates or aggregates rapidly to form larger structures. These structures will then 
sediment and deposit more quickly onto the cell surface, and therefore may be internalized 
at a faster rate than initially predicted based on the primary NM size, due to increased 
contact.  An alternative scenario is that agglomerates and aggregates may be too large to 
enter cells, leading to a reduction in internalization rate (Hussain et al., 2009). 
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A small toxic NM may sediment slowly, and therefore over the same administered dose, and 
the same experimental time course, the contact dose and internalized dose could be 
substantially lower than in the case of a larger but less inherently toxic NM (DeLoid et al., 
2017). As a result, the larger NM suspension may lead to an apparent increase in cellular 
toxicity due to the higher received dose, and be reported as more toxic than the smaller NM, 
as the delivered dose was higher (DeLoid et al., 2017). It is worth noting that dose is 
inevitably not the only cause for increases or decreases in toxicity.  Parameters such as 
shape, surface coating, protein corona, shape and core will all influence toxicity. However, in 
situations where the delivered dose of NMs differs over the same experimental time course, 
toxicity assessments can be confounded and comparisons between the NMs cannot be 
accurately made unless these dose effects are properly measured and accounted for. 
Experimentally, it was shown that the delivered dose of NMs might be low for particles 
smaller than 100 nm when diffusion plays a predominant role (L.K. et al., 2005; Teeguarden 
et al., 2007a; Lison and Huaux, 2011). However, this also depends on the density of the 
material and for instance we have determined that with polymeric NMs like PS of 50 nm 
diameter, the transport in the extracellular medium for NM to reach the plasma membrane 
is not rate-limiting (Salvati et al., 2011). Besides the physicochemical properties of NM and 
medium, other aspects of the exposure or experimental procedure can influence the time of 
NM transport, including the container volume, the medium height, stirring, and interactions 
with biomolecules, as discussed below. 
 
Role of container and medium height 
The medium height describes the distance that NMs in suspension must travel in order to 
come into contact with the floor of the vessel (or the cells plated at the bottom of the 
vessel). Medium height can affect both the sedimentation and diffusion of NMs. As stated 
previously, diffusion time increases with the square of diffusion distance, thus a linear 
increase of medium height, regardless of the increase in administered dose, results in a 
distance squared increase in the diffusion transport time. In particular, this highlights the 
importance of maintaining consistent media height in and across experiments, as altering 
this could confound comparisons between different NMs. Likewise, decreasing the volume 
and subsequently the media height might conversely lead to an increase in the number of 
18 
 
NMs in contact with cells. This could have implications for comparisons between different 
approaches, for example, toxicity studies performed in 96 well plates versus NM uptake 
studies imaged by confocal microscopy where the coverslips are cultured in 6 well plates. 
However, with the correct reporting this can be compensated for by recalculating cellular 
dose, accounting for well size and volume. In several cases it has been noted that 
extracellular NM concentration is in large excess compared to uptake levels, thus the 
extracellular NM reservoir can be considered substantially fixed during the full length of the 
experiment, provided the exposure time is not on the order of days (Kim et al., 2012). Media 
height could be a problem particularly in toxicity assessments that take place over long 
durations, whereby the medium volume will evaporate over time, altering the transport in a 
time dependant manner. It is therefore critically important to record changes in the medium 
height over time or to replenish media using continual flow to maintain media height (Bjo et 
al., 2016). Moreover, in the case of decreased extracellular volume and low concentration of 
NMs, additional complications due to NM depletion, NM dissolution and subsequent 
concentration changes following uptake may arise. This implies that it is important to include 
consideration of extracellular volume in the description of the experiments performed. 
Likewise, in chronic, continual or repeated exposure scenarios where medium is constantly 
replenished with new treatment media, more complex methods for monitoring and 
evaluation of medium height, NM transport and dosing over the period would be necessary. 
In these types of experiments, sophisticated systems for delivering specifically determined 
doses or measuring delivered doses would be required to enable accurate calculations of 
cellular dose over the entire time period, such as those used in a 14 week chronic dosing of 
AgNPs to skin cells (Comfort et al., 2014). This highlights the critical nature of NM 
characterization under the correct experimental conditions and time courses – NM 
dissolution, and NM concentration and/or medium height changes over time should all be 
properly characterized, along with physicochemical characterizations prior to in vitro testing. 
The size and shape of the container is an important aspect of the settling velocity of NM 
suspensions, as shown in Figure 5 based on experimentally determined settling dynamics of 
fibres (Herzhaft and Guazzelli, 1999). Open containers often exhibit meniscus effects and 
hence the inhomogeneous NM surface distributions. The use of closed containers, such as 
channels, leads to homogeneous NM distributions. 
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Surface effects: meniscus and well 
The type of chamber (open versus channel chambers), the size of the chamber, and the 
material of the chamber have an additional impact on surface properties, such as roughness 
and polarity. These surface effects (e.g., surface tension) may change local medium 
composition or concentration of NMs, thereby influencing the transport processes and time, 
as mentioned above.  In channel chambers or culture wear, NMs may be adsorbed onto the 
surfaces (heteroagglomeration), changing the number of NMs available to be taken up or 
interact with the cells; again if some NMs are removed from the system through absorption, 
particularly if this is size specific as suggested, the transport of the remaining NMs will differ 
from that of the initial suspension. Moreover, a local increase in concentration in a specific 
part of the chamber could destabilize the suspension, increasing the likelihood of 
interactions such as agglomeration, again modulating the transport of the resultant NMs. 
Experiments could be performed to calculate the recovery from chambers and wells to 
determine the amount of NM binding in different containers of different materials to account 
for this in experiments. For metallic NMs, this test of NM binding can be performed by 
conducting the experiment within the culture vessels to be used but without the presence of 
cells, and for example NM (and ionic) concentrations could be tested (e.g. by single particle 
Inductively-coupled plasma mass spectrometry (spICP-MS)) prior to, and after incubation 
with culturewear to determine the NMs remaining in the media at certain time intervals and 
the amount lost; this would also provide valuable information regarding the dissolution 
during the experimental time course (Aznar et al., 2017).  For non-metallic NMs, intrinsic 
fluorescence, Raman or other detection approaches could be applied, but often have lower 
sensitivities. 
 
Exposure including convection and stirring 
The presences of agglomerates and aggregates complicate the modelling and analysis of 
dose-metrics and toxicology data. Both agglomerates and aggregates tend to settle and 
amass, leaving a portion of the cells with a very low delivered dose. To bypass this problem 
the delivery of NMs can be made under agitation. Mixing and heating affect the variability of 
the fluid composition, the Brownian motion, the transport towards the cell surface, and 
ultimately, the delivered dose. In the presence of convection forces all the NMs, regardless 
their size and density, might be able to reach the bottom of the container and therefore be 
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active on the cell surface (Lison and Huaux, 2011). However, stirring or heating of a NM 
solution can increase the number of collisions, thus increasing the likelihood and frequency 
of agglomeration. In dispersions where agglomeration occurs, competition between diffusion 
and sedimentation phenomena are more difficult to predict, however using the equations 
mentioned earlier, and accounting for these different agglomeration rates, models have been 
constructed that can mimic this effect when calculating the delivered dose (Hinderliter et al., 
2010; DeLoid et al., 2017). Agglomeration and aggregation change NM size and surface area 
and increase the gravitational settling, in other words the presence of agglomerates and 
aggregates transforms a dispersion of NMs. Characterization of the stability of a NM 
suspension, particularly in the relevant media for exposure, is therefore necessary in a 
nanotoxicity study because, ultimately, the stability (or lack thereof) modifies transport in 
cell culture medium and affects the time a NM dwells in that environment, and hence also 
their bioavailability.  Stability should therefore be assessed under the exposure conditions 
for, at a minimum, the experimental time course at appropriate conditions, i.e. 37 °C in the 
same vessel in which they would be applied to cells. Stability assessments generally include 
measuring the zeta potential to determine electrostatic or steric stabilization of the NMs, DLS 
to measure particle agglomeration and stability of the size distribution, and NM solubility in 
control and test medium, all of which will affect the transport and behaviour of the NM 
suspension (De Campos et al., 2004; Moore et al., 2015; Nur, Lead and Baalousha, 2015; 
OECD, 2016; Rossi et al., 2016; Avramescu et al., 2017; Gao and Lowry, 2018). 
 
NM-protein corona effects: cell media and exposure route 
NM size, shape and surface charge have been described as important determinants of uptake 
(into cells and tissue) and toxicity (Wilhelm et al., 2003; Alkilany and Murphy, 2010; Huang et 
al., 2010; Fröhlich, 2012; Huk et al., 2014; Kettler et al., 2014; Bjo et al., 2016). It has also be-
come increasingly apparent that the layer of proteins that adsorb at the NM surface and 
form the dynamic ‘protein corona’ play a key role in modulating the interactions between 
NMs and living cells, in particular regarding targeting and uptake behaviour (Nel et al., 2009; 
Monopoli et al., 2011, 2012; Lesniak et al., 2012; Salvati et al., 2012). The high reactivity of 
NM surfaces makes the adsorption of proteins, ions and other molecules in solution easier.  
As a consequence, as soon as NMs are dispersed in a biological fluid, proteins or other bio-
molecules immediately adsorb to their surface, changing their physico-chemical characteris-
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tics (i.e., size, charge and biological activity). Cell media usually contains serum or other 
charged biomolecules, which modify the NM surface, forming the so-called NM-protein co-
rona (Cedervall et al., 2007; Klein, 2007; Nel et al., 2009; Monopoli et al., 2011, 2012; Pino et 
al., 2014; Yallapu et al., 2015). This leads to a new 'biological identity' of the NMs, with dif-
ferent size, charge, and surface properties. These size changes can disturb the Brownian mo-
tion and the transport phenomena as previously described, and changes in the NM surface 
charge can alter the affinity for the cell surface or the interaction with petri dishes and ions 
in solution, and therefore ultimately the bioavailability. Therefore, corona formation can alter 
the stability of the NM dispersion and modify the interaction with cells (Lynch, Salvati and 
Dawson, 2009; Tenzer et al., 2011, 2013; Lesniak et al., 2012; Bertoli et al., 2016). Indeed, in 
the absence of biomolecules in the cell culture media the high surface reactivity of NMs re-
sults in significant cellular damage and the acquisition of a corona from biomolecules pulled 
out from the cell through membrane damage (Lesniak et al., 2012).  A complete understand-
ing of how the properties of NMs and their surroundings modulate the corona formation will 
aid advancements for NM targeting immensely and will be crucial in understanding and pre-
dicting the biological effect and fate of NMs, both from direct exposure (e.g. nanomedicine) 
and indirect exposure (e.g. via the environment (Lynch et al., 2013, 2014)). 
 
The NM corona constitutes the primary point of interaction between the NMs and biological 
components and is known as the ‘nano-bio interface’ (Nel et al., 2009). Due to the formation 
of this protein corona, the presence or absence of serum proteins in cell culture studies has a 
major impact on subsequent effects (Lesniak et al., 2012; Cheng et al., 2015; Fleischer and 
Payne, 2015; Ritz et al., 2015; Shannahan, Podila and Brown, 2015). The presence of the 
protein corona can modulate cellular internalization patterns, and lead to increases or 
decreases in NM uptake a cell specific manner.  In several cases it has been reported that 
uptake of NMs in the absence of proteins (serum free conditions) is much higher than the 
uptake observed in the presence of serum (such as FBS), likely due to a reduction in non-
specific binding of the NM at the cell surface in comparison to that observed in the absence 
of proteins (Lesniak et al., 2012; Smith et al., 2012b). This is supported by the observed 
increase in the binding of NM to the cell surface in the absence of proteins, indicating that 
interactions between the membrane and the bare NM lead to adhesion at the cell surface 
and increased likelihood for internalization (Smith et al., 2012b; Lesniak et al., 2013). Lesniak 
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et al also demonstrated that SiO2 NMs exposed under serum free conditions had acquired a 
protein corona within 1 hour of exposure, by pulling proteins from the cell membrane 
(Lesniak et al., 2012).  It is suggested that the NM protein corona, in a static environment, 
can reach steady state in minutes to hours (Albanese et al., 2014). Albanese et al, reported 
the evolution of the corona following the release of proteins and nutrients from the cells (in 
a process they term conditioning) (Albanese et al., 2014). Some of these secreted proteins 
may have a higher affinity for the NM surface than the previously bound proteins, leading to 
exchange and evolution of the corona during the entire exposure time (Albanese et al., 
2014). Albanese et al determined an optimum NM incubation time of 4 hrs in the 
conditioned media prior to protein corona characterization, but postulate that time-
dependant changes in vivo are likely to be far less remarkable than the changes that occur 
due to translocation through blood and tissues (Albanese et al., 2014). Based on their 
findings, corona characterization should be performed in both unconditioned and cell 
conditioned media to give the best indication of the biocorona evolution. 
 
Based on the above discussion, it becomes evident that experiments that are performed in 
the absence of proteins or other biomolecules are not biologically relevant as bare, uncoated 
NMs will not be present in biological fluids in vivo, as protein and biomolecule adsorption 
occurs almost instantaneously, and indeed even under serum free conditions the NMs 
rapidly pull proteins from the cells to form a corona (Lesniak et al., 2012). In this context, the 
use of different concentrations of FBS may also need to be investigated in terms of corona 
composition and evolution. It is known in fact that the corona formed on the same NM 
changes when different protein concentrations are used, for instance to resemble more 
closely the protein concentration present in vivo in human serum, as opposed to the more 
diluted serum concentrations typically used in in vitro studies (Monopoli et al., 2011). The 
concentration of proteins of the media not only changes the composition of the corona but 
also affects the overall uptake levels into cells, thus the effective dose delivered (Kim et al., 
2014). Another important factor is the source of the serum proteins. Individual batches can 
vary in composition and quantity of bioactive compounds, therefore centralized batches of 
serum are favoured for large scale NM studies and new emerging serum free alternatives are 
an area of interest (Baker, 2016). Indeed centralized batches of serum are commonly used in 
large interlaboratory comparisons such as those organised within QualityNano and other 
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similar efforts (see Salvati et al, in this special edition). Thus, the exposure conditions should 
be fully specified in terms of composition of the extracellular medium, and the composition 
of the corona itself as thoroughly as possible. 
 
Uptake of nanoparticles into cells 
Different cell types are designed to carry out very different specific functions in vivo; this 
leads to varied cell surface protein / receptor expression, internalization mechanisms and 
detoxification processes (Kuhn et al., 2014a). The extent and fate of cellular accumulation 
can depend largely upon the internalization mechanism utilized and the properties of not 
only the NMs, but also the cells themselves (Kettler et al., 2014). It has recently emerged 
that the proteins bound at the surface of the NMs (such as those present in the corona) can 
be recognized by cell surface receptors, leading to NM internalization and trafficking via the 
endo-lysosomal system (Bertoli et al., 2016; Lara et al., 2017). Coating with serum proteins 
thus confers specificity to NM internalization pathways upon binding to a membrane recep-
tor, an example is that of the transferrin receptor (TfR), whereby transferrin presence in the 
protein corona leads to the subsequent internalization through TfR interaction and clathrin 
mediated endocytosis (Figure 2) (Mazzolini et al., 2016). In some cases however binding and 
recognition of a certain corona protein may activate internalization via pathways that differ 
from that usually triggered by that protein (Mahon et al., 2012). Protein coated NMs could 
therefore be internalized preferentially by different uptake machinery, dependent upon the 
proteins present in the NM corona, and pathways active within a cell or cell population, and 
can therefore greatly influence cell uptake, fate, localization and toxicity (Aggarwal et al., 
2009; Lesniak et al., 2010, 2012; Oberdörster, 2010; Mortensen et al., 2013; Treuel et al., 
2014; Wolfram et al., 2014; Grafe et al., 2015; Bertoli et al., 2016; Mazzolini et al., 2016). It 
has been suggested that the presence of apolipoproteins, such as Apo E or Apo H, in the co-
rona of NMs could lead to higher uptake efficiency, and indeed Apo E and ApoB-100 are also 
known to support the transport of NMs across the Blood Brain Barrier (BBB) (Kreuter et al., 
2002; Wagner et al., 2012; Wolfram et al., 2014; Ritz et al., 2015; Neves et al., 2017). More 
recently it was demonstrated that overexpression of specific cell receptors, such as the trans-
ferrin receptor, low density lipoprotein receptor and Fc-gamma receptor 1, can lead to in-
creases in NM accumulation (Mazzolini et al., 2016; Lara et al., 2017). The interactions be-
tween NMs and proteins is therefore crucial to study, both in terms of determining NM up-
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take patterns, but also to investigate any conformational changes that occur to proteins due 
to the NM binding, which can affect their receptor-binding efficiency.  Approaches to achieve 
this are beyond the scope of this review, but a short discussion on this is included in the Sup-
plementary Information. 
 
This receptor mediated internalization can lead to subsequent degradation and release of 
NM metabolism products within the cell, such as free ions and components of the NM coat-
ings, leading to toxic responses such as generation of ROS and DNA damage (Arbab et al., 
2005; Lara et al., 2017).  NMs have been found to utilize a variety of mechanisms to enter 
different cell types, including membrane permeabilization and dynamin dependant path-
ways, clathrin mediated and caveolae mediated endocytosis or clathrin-independent endocy-
tosis (Rejman et al., 2004; Yang et al., 2007; Dausend et al., 2008; Smith et al., 2012a; Zhu et 
al., 2013; Mazzolini et al., 2016).  However, there is still no clear factor that determines which 
route is preferentially employed and the detailed mechanisms NMs use to enter cells still 
remain unclear (Iversen, Skotland and Sandvig, 2011). A variety of methods are available to 
investigate this specific uptake including drug and siRNA inhibition studies, fluorescence con-
focal colocalization studies and reflectance imaging (Daldrup-Link et al., 2003; Matuszewski 
et al., 2005; Stefaan J. H. Soenen et al., 2010; dos Santos et al., 2011; Sandin et al., 2012; 
Kuhn et al., 2014b; Guggenheim et al., 2016). These different approaches have various ad-
vantages and limitations: for instance fluorescence studies require fluorescently detectable 
NMs, reflectance methods require optically dense NMs, colocalization studies are limited by 
the resolution of the imaging system and the quantification methods employed, and drug 
inhibition of cellular pathways can lead to cell-wide cytotoxicity (Bolte and Cordelieres, 2006; 
Stefaan J H Soenen et al., 2010; Iversen, Skotland and Sandvig, 2011; Pike et al., 2017). New 
emerging combinations of techniques can circumvent some of these problems, such as the 
use of correlative reflectance and Transmission Electron Microscopy (TEM) investigations. In 
these investigations, light microscopy (LM, confocal or superresolution) can be employed to 
measure the effects of specifically inhibited pathways alongside the visualization of labelled 
compartments and cellular features in fixed or living cells.  Ultra-high resolution can also be 
maintained using Electron Microscopy to visualise individual NMs and the cellular ultrastruc-
ture (Guggenheim et al., 2016). This permits identification of subcellular localization and na-
ture of signal, colocalization of NMs with labelled components and the visualization of the 
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cellular ultrastructure. Correlating these methods also allows the visualization of dynamic 
events using LM, followed by high resolution investigation at a fixed point within the dynamic 
process providing valuable information that may otherwise have been missed (Karreman et 
al., 2016). 
 
Despite the idea that cellular dose, and subsequent NM internalization, is largely responsible 
for cell cytotoxicity, it is not the only potential source of deleterious effects. NMs have been 
suggested to elicit cell signalling responses that can lead to subsequent cellular stress via 
paracrine methods, such as inducing the release of proteins such as cytokines (Raghnaill et 
al., 2014). In this way, NMs can affect other cells without the need for actual physical interac-
tion. Cobalt chromium NM exposures on one side of a multi-layered barrier, for example, 
have been found to lead to cytotoxic effects such as DNA damage and chromosome aberra-
tion to unexposed cells on the other side of this barrier without actually crossing (Sood et al., 
2011). Another study indicated that the interaction of carboxylate modified polystyrene (PS-
COOH) NMs with the BBB, for example, led to changes in the levels of pro-inflammatory and 
pro-survival cytokines, such as RANTES, TNFR1 and EGF, released in the presence of glial cells 
with which they were not in physical contact (Raghnaill et al., 2014). These subtle effects of 
NMs would largely be missed by the traditional acute toxicity testing strategies, and an im-
portant consideration when making toxicological assessments of NM is their accumulation 
potential, subsequent cellular stress and the potential for effects on paracrine signalling be-
tween cell types. 
 
Modes of NM exposure in cell culture 
This section discusses the existing approaches to present NMs to cells and how they translate 
 into requirements SOPs. 
 
Upright exposure of NMs to adherent cells 
The most common mode of NM exposure for standard submerged adherent cell cultures is 
the addition of NMs in the extracellular medium as depicted in Figure 1. Still, even in this 
standard configuration, the ways NM dispersions are prepared and added can be multiple 
and this can lead to different results. To illustrate this, experimental data provided in five 
different articles which studied TiO2 NM interactions with adherent cells in an upright 
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configuration, were assessed. The data are summarised in Table 1.  In each case it was stated 
that the NM dispersion was diluted into cell culture medium following sonication. The 
duration of the sonication step varies extremely between publications, as shown in Table 1. 
The DSE was not calculated or optimized in any case, which has previously shown to be of 
importance, however in three of the cases the sonication energy was provided (DeLoid et al., 
2017).  Furthermore, the inclusion of FBS differed between the studies, 3 included FBS, 1 was 
omitted FBS and 1 did not state whether FBS was present or not. The effect of the inclusion 
or omission of FBS in cell studies has been studies in depth, as previously discussed. After 
addition to cell medium, the NM suspensions were characterized in all cases by at least one 
technique. However, it is important to use at least two size characterization methods, due to 
the necessity to measure core and hydrodynamic size following immersion in different fluids; 
different techniques measure different size end-points. In one case only the DLS size was 
reported, giving no information regarding the result quantified from the TEM measurements 
nor the nominal size of the NM. Different multi-well plates were used in all studies, which as 
discussed, would lead to changes in the delivery and quantity of the NM dose, but if correct 
parameters were recorded, could be accounted for and allow comparison across the studies. 
In each case the size of the well was recorded, however variations exist between 
manufacturers, which will lead to small changes in the total surface area and therefore the 
manufacturer should also be reported to enable accurate calculations. The incubation time 
was reported as 24 hrs, independent of the height of the media and the size of the NMs, 
therefore the dose delivered to the cells would have been different in each case – and was 
not calculated, rendering comparisons impossible. Additionally, the total volume of NM 
suspension added per well was given in only one of the five publications assessed (see Table 
1). Consequently, parameters such as the height of the liquid column (which will affect the 
diffusion and sedimentation of the NM) or the total amount of NMs added to the cell culture 
remains unknown in the cases where the media height is not given, therefore the cellular 
dose cannot accurately be calculated. There are currently no standard units for the recording 
of NM concentration in solution, which is often given in µg/mL (4/5 cases) or µg/cm2 (2/5 
cases) – in one case it was given in both. The cell seeding density, cell density at exposure 
and cell size should also be recorded, to allow accurate calculations of NM dose per cell 
(where all other parameters are recorded). Inclusion within SOPs of automated techniques 
that calculate the number of cells in a microscopical field of view, or by means or alternative 
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cell counting methods, to extrapolate to estimates of cell number within the dish would be 
of benefit here, a technique validated previously (Jaccard et al., 2014). If appropriate 
measurements of these aforementioned experimental metadata are recorded, then cellular 
dose can be calculated (following experimental determination of the effective densities and 
ENM dissolution) using models such as the ISSD or the more recent Distorted Grid model 
(Hinderliter et al 2010; DeLoid, 2017). Ideally, the delivered cellular dose in vitro (and in vivo) 
would be measured directly, using techniques such as spICP-MS, however the cost and/or 
availability of such techniques in biology labs is often limited.  
 
Within the QualityNano research infrastructure, extensive work was performed to develop 
standardized protocols for different assays in nanosafety testing, such as to quantify 
nanoparticle uptake by flow cytometry and to measure nanoparticle-induced cytotoxicity 
(Salvati et al., 2017). In order to minimize interlaboratory variability that could generate from 
all of the aspects discussed above, the developed SOPs also included details on how to 
perform cell seeding, NM dispersion preparation in cell culture medium and exposure to 
cells.  Prior to further testing on cells, participating laboratories were asked to demonstrate 
their proficiency in cell culture, following the SOPs for cell culturing and for assessment of 
cell growth (thee SOPs are included in Nelissen et al. 2017). For these tests, lung cancer 
epithelial A549 cells were selected as a common model cell line easy to maintain and often 
used in nanosafety testing. In order to limit the variability arising from differences in cell 
handling and storage procedures, frozen cells amplified from the same initial cell stock at the 
same passage number were provided to all laboratories. Similarly, FBS from a common stock 
was distributed. Different serum batches are known to have different protein composition 
and concentration as mentioned previously: this can affect cell growth and proliferation rate. 
Additionally, when serum is used to prepare NM dispersions, it can lead to differences in NM 
stability and the corona composition, thus ultimately leading to different behaviour in cells. 
NM dispersions in water were prepared from a common stock and aliquots shipped to all 
laboratories. Reporting forms were developed to record all details and timing of cell culture 
medium preparation, aliquotting of the received FBS stock, cell defrosting and sub-culturing. 
Further details of the quality control procedures and process are provided in the 
Supplementary Information. The NM uptake SOP and NM-induced cytotoxicity SOPs 
contained details on how to prepare the cell dilution for cell seeding and the volumes of the 
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diluted cells to be added to each well for the different multi-well plates used. Additional 
precautions were taken to limit clumping of the cells to the periphery of the wells due to 
edge effects and obtain a more uniform cell density throughout the well (see Nelissen et al. 
for details). NMs known to form uniform and stable dispersions in cell culture media 
containing FBS, such as PS-COOH NMs and amino-modified PS (PS-NH2) were specifically 
selected for these interlaboratory comparisons. For these PS NMs, simple vortexing ensures 
preparation of good dispersions (as mentioned above other particles are known to require 
much more complex dispersion protocols). Even though the procedure is relatively simple, 
the SOPs contained details on the volumes added, order of mixing, pipetting strategy 
(forward pipetting etc.) speed and time of vortexing and timing between preparation and 
addition to cells, all factors that could affect the final outcome. Additionally, variability due to 
NM preparation was estimated by preparing 3 separate NM dispersions, each representing a 
separate technical replicate. A separate dosing plate was used to prepare serial dilutions 
from 3 freshly-made NM dispersions in cell culture media at the highest concentration 
tested. Finally, cells were exposed to the NM dispersions by replacement of the extracellular 
media with specified volumes of the freshly-made NM dispersions from the dosing plate.  
Addition of small volumes of NMs at higher concentration directly into the wells containing 
cell culture medium can be more difficult to control and can lead to strong differences in 
exposure for the different cells within the well. Overall, by taking into account all of these 
details, the cell growth proficiency test, NM uptake studies by flow cytometry and NM-
induced cytotoxicity assays, all gave highly reproducible results in independent laboratories 
(see Nelissen et al and Salvati et al for details). It is clear that this kind of SOP captures many 
more details and instructions compared to what is typically reported in the experimental 
sections of published articles (e.g. 8 page protocols, as indicated in Nelissen et al and Salvati 
et al). 
 
 
Other modes of NM exposure to cells 
As discussed previously, NM consisting of various materials and with different sizes and 
shapes show different sedimentation and diffusion rates, leading to different cellular doses 
of NM over time. NMs are heterogeneously distributed to the cells particularly in the 
standard upright configuration whereby NM dispersions are placed over cells (Figure 3).  
29 
 
Other techniques exist for cellular exposure of NMs, including surface based, whereby NM 
are decorated onto a solid surface, inverted culture and air-liquid interface (ALI).  Figure 3 
presented an overview of the different modes of presentation available, and here these are 
described in more detail, and related to the parameters required as part of the SOP to ensure 
comparability with other studies and the classical submerged culture approach (see Table 2 
and section ‘Recommended Reporting’ and appendix ‘Protocol’). 
 
Surface based presentation of NMs to cells 
In the surface based presentation of NMs to cells, NMs are immobilized onto the surface pri-
or to cell exposure and cells seeded on top of the NM layer, as shown schematically in Figure 
3 (Alberola and Rädler, 2009). This circumvents some of the problems associated with up-
right culture treatment, as the NM are static, and thus do not undergo agglomeration. A de-
fined number of attached NMs on the surface can be obtained by tuning the NM absorption 
time and the NM concentration in solution. Figure 6 shows an example of homogeneous 
Quantum Dot (QD) distributions achieved by varying the NM concentrations in solution (Al-
berola and Rädler, 2009). This prevents fluctuations in the number density throughout the 
surface which is important in minimizing the cell to cell dose variability when evaluating cell 
response in toxicity assays (Snijder and Pelkmans, 2011). Moreover, it enables the precise 
definition of the NM dose to which the cells are exposed. 
 
This type of set-up confers some advantages; the exact number of NMs/µm2 is known and 
pre-defined and the problems associated with NM agglomeration / aggregation and inhomo-
geneous distribution over time are circumvented (Alberola and Rädler, 2009).  The monitor-
ing of the NM uptake process is also simplified because the NMs, which are initially absorbed 
on the two dimensional reference surfaces (µg/cm2), are lifted above the reference plane 
when they are taken up by the cells.  Uptake can therefore be assessed by evaluating the po-
sition of the NMs in a stack of z-scans from confocal microscopy. 
In the surface based NM presentation, the interactions between the NMs and the substrate 
play an important role which should not be neglected. This interaction must be sufficiently 
strong for the NMs to stay in place after rinsing and the addition of cell medium. However, 
strong interactions of NMs with the surface can shield the NM-cell interaction and thus likely 
modulate the internalization efficiency of these systems. For example, when carboxyl func-
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tionalized QDs where bound to a poly-L-lysine surface, the cellular uptake was drastically re-
duced in comparison with an uncoated substrate (Alberola and Rädler, 2009).  These systems 
indicate active uptake processes must be involved due to the uptake against gravitation and 
surface attraction forces (Alberola and Rädler, 2009). However, the effect that the surface 
binding of NM to the substrate prior to cellular uptake has on the internalization mechanism 
should also be carefully considered and evaluated. This configuration also provides a means 
to investigate the gain and loss of NM over time via endo and exocytosis, as a set number of 
NMs are present within the system. Surface based presentation-type configurations could be 
useful for mimicking particular in vivo conditions, whereby NMs are static within dynamic 
conditions (such as QCM measurements for NM/receptor binding). NM could also be em-
bedded within or exposed to an extracellular matrix and presented to cells via or following 
ECM-interactions. NMs are known to interact with many ECM components, and NM diffusion 
through ECM has been studied previously (Sykes et al., 2016; Engin et al., 2017). These NM-
ECM interactions are undoubtedly going to have an effect on the cellular uptake (and the 
properties of the surrounding ECM itself) which may be important for the translation of po-
tential cancer therapeutic or diagnostic agents for in vivo success as delivery vehicles (Sykes 
et al., 2016; Millard et al., 2017). 
   
Inverted cell culture systems 
Inverted cell culture systems have been suggested as particularly well-suited for buoyant NM 
exposure conditions (Figure 3) (Spyrogianni et al., 2016). In an inverted system, the cells are 
attached at a coverslip and suspended into the media from above. The use of inverted 
systems can be preferential when the NMs have a low effective density compared to the 
medium, these systems have therefore been compared to the use of standard upright 
exposure conditions (Watson et al., 2016). Polypropylene (buoyant) NMs led to cellular 
toxicity only in the inverted configuration, and not in the upright configuration, indicating 
limitations of current systems that rely solely on the upright configuration (Watson et al., 
2016). One study compared the effects of soluble and insoluble NMs in both configurations, 
whereby it was observed that dissolvable NMs showed no difference in the toxicity using 
either technique, when it was the ion itself known to cause the toxicity (Spyrogianni et al., 
2016). However insoluble particles exhibited different sedimentation rates and therefore 
deposited doses, leading to observable differences in cytotoxicity (Spyrogianni et al., 2016). 
31 
 
In upright configurations NM will come into contact with cells through both diffusion and 
sedimentation, where in inverted configurations NM exposure to cells will be through 
diffusion only, and sedimentation will lead to loss of material and lower available NM 
number. One study compared this effect using different size and composition NMs, all of 
those larger than 15 nm but smaller than 118 nm showed greater uptake in the upright 
configuration, but differences were more prominent in the larger particles (Lison and Huaux, 
2011). Smaller particles, less than 15 nm showed similar uptake in both arrangements, 
presumably due to their predominant diffusional movement, those larger than 118 nm had 
larger sedimentation forces and showed much greater uptake in the upright configuration 
(Lison and Huaux, 2011). This work highlights how culture conditions can modify the 
delivered dose in a significant way and has important implications for toxicity studies. 
 
Another approach to control NM exposure to cells could be to first let the NMs adhere on 
the cell surface in conditions in which uptake is inhibited (for instance by energy depletion at 
lowered temperature – 4 ºC) and then let the adhered NM enter cells after the extracellular 
NMs are removed. Such an approach, although far from real biological conditions, has been 
applied in order to determine the role of the initial adhesion to the cell membrane in the 
overall uptake level and to explain the observed differences in NM uptake in the presence or 
absence of a corona on the NM surface (Lesniak et al., 2013). The comparison of the uptake 
achieved after increasing the incubation temperature of the NMs that had previously had 
lower temperature, with the uptake measured after continuous exposure in physiological 
conditions (at 37 ºC) determined that the initial adhesion to the cell membrane is a very fast 
and crucial step in NM internalisation and that it is strongly affected by the presence or 
absence of proteins on the NMs. 
 
Air-liquid interface in vitro 
Despite the existence of the aforementioned exposure methods, including upright, inverted 
and substrate attached NM configurations; these can still not accurately represent some 
physiological exposure conditions.  Adverse effects that can occur due to inhalation of NMs 
are an important consideration, and traditional in vivo inhalation studies have several 
associated drawbacks in regards to the use of animals, need for facilities, cost and poor 
translation of effects (Clippinger et al., 2016). Therefore considerable effort has been 
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undertaken to mimic relevant exposure conditions in the lung in a method termed air liquid 
interface exposure (ALI) whereby an automated station can expose cell cultures directly to 
airborne or aerosolized substances such as NMs and fibres (Hedwig M Braakhuis et al., 2015; 
Clippinger et al., 2016; Latvala et al., 2016; Mülhopt et al., 2016; Polk et al., 2016; Geiser et 
al., 2017).  In the ALI exposure, cells are plated in trans-well formation, with the media 
below, and the exposed cell surface available for interaction with the applied aerosols (Figure 
3) (Polk et al., 2016). This type of culture system has several advantages, particularly for the 
assessment of airborne pollutants and aerosolized NMs.  The exposure conditions mimic lung 
inhalation studies, and the delivery of the gas phase NMs circumvents a variety of problems 
associated with standard cell culture techniques. The NM delivery is dynamic and controlled 
through an inlet at the top of the chamber, and these NM can be tested directly without 
changing the properties (e.g. by dispersion in serum containing medium), in addition to 
bypassing agglomeration effects and the effects of NM delivery within a bolus form, such as 
that used in standard culture systems. As such, there is now a range of commercially 
available ALI devices, including ALICE, NACIVT, MINUCELL, VITROCELL and CULTREX systems 
(Bakand, 2016). ALI devices have been demonstrated to represent a valid model for the 
toxicological assessment of poorly soluble NMs, including MWCNTs (Chortarea et al., 2015; 
Clippinger et al., 2016; Loret et al., 2016; Polk et al., 2016). MWCNTs often have high aspect 
ratios and their low solubility have raised concerns that long term exposure could lead to 
lung pathologies seen previously with other fibrous particles (Oberdörster, 2010). Therefore 
efforts are being made to investigate the effects of such NMs using ALI methods (Endes et 
al., 2014; Chortarea et al., 2015; Polk et al., 2016; Beyeler et al., 2017). A study using one 
such ALI method was combined with a 3D in vitro model of the epithelial airway barrier, 
combining both sophisticated delivery and a multicellular 3D physiological cellular 
environment to investigate these high aspect ratio CNTs (Endes et al., 2014; Chortarea et al., 
2015). Clearly the combination of physiologically relevant exposure and physiologically 
relevant cellular environments can provide new insight into the potential toxicity of NMs. 
The effect of chronic to acute exposure to CNTs were assessed and compared using this 
methodology indicating changes in the levels of the antioxidant glutathione (Endes et al., 
2014; Chortarea et al., 2015). 
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These ALI devices have been used in the evaluation of early cytotoxicity to cells following 
exposure to airborne NMs, and pollutants resulting from diesel and gasoline engines (Herzog 
et al., 2013; Lenz et al., 2013; Mülhopt et al., 2016; Kooter et al., 2017). In the cases of 
pollutants, the toxicity of the gas phase NM, compared to the removed NM which were 
subsequently re-suspended in upright culture was markedly increased, indicating the value 
of this technique in such studies, and the necessity to use the right cell exposure 
configuration (Mülhopt et al., 2016). ALI systems have also showed significant value in the 
assessment of aerosols generated by engineered NMs that were previously unattainable 
using standard culture configurations, such as in the case for zinc oxides, copper oxide and 
nickel oxides where levels of cellular toxicity were observed at much lower doses in ALI 
systems compared to standard culture (Holder et al., 2008; Lenz et al., 2013; Kooter et al., 
2017). ALI exposure of 3D epithelial co-culture models to AgNPs also provided insight into 
the lack of toxicity of these NPs at realistic exposure concentrations (Herzog et al., 2013). In 
these systems the number of NMs deposited at the ALI corresponds closely to the modelled 
number concentration expected to be observed in tracheal-bronchial regions of the lung; 
however smaller particles are not deposited as efficiently as larger particles so optimization 
is sometimes necessary (Holder et al., 2008). 
  
Clearly there are a vast amount of considerations in terms of the different ways in which to 
dose cells with NMs. In vitro toxicity assays should be designed such that they can ultimately 
predict toxicity in vivo and thus replace, at least in part, in vivo assays in-line with the 3R 
framework (Fischer and Chan, 2007; Stone, Johnston and Schins, 2009; Burden et al., 2017). 
In terms of deciding upon the culture configuration to use, the question that naturally arises 
is which conditions are more representative of the in vivo exposure being assessed. Naturally, 
this depends on the system, exposure route and process to be modelled. If the purpose is to 
study NM cellular uptake after inhalation, none of the upright, surface nor inverted approach 
is adequate, since the epithelial cells in the lung are polarized and the NMs would be 
exposed to them from the basal side instead of the apical side, as happens in natural 
conditions. Therefore, the only appropriate method is using ALI whereby the apical side is 
exposed to aerosol as it would be in vivo. For studies within cells that do not show 
polarization, such as fibroblasts, the location of the NMs may be less crucial. If the aim is to 
study how NMs are eliminated from the body, travelling from the blood stream towards the 
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lumen of an organ, the surface based presentation would allow observed uptake from the 
basal membrane of epithelial cells. For example, it has been shown that the uptake rate of 
fluid-phase markers over the basal side was six times higher than for the apical side due to 
the bigger area of basolateral surface domains (von Bonsdorff, Fuller and Simons, 1985). In a 
more physiologically accurate method, microfluidic devices allow for the introduction of 
cellular perfusion in single or multicellular 2D and 3D structures, these are discussed more 
later in the section ‘NM uptake and transport under more physiological conditions’ (Tian and 
Finehout, 2008; Prabhakarpandian et al., 2011; Rennert et al., 2015). 
 
Nevertheless, regardless of which configuration is used there is a minimum requirement for 
information and standardization of these procedures, of which there has been considerable 
debate. Several of these have been discussed or introduced in the previous sections. 
Recordable attributes include experimental parameters such as the cell type and exposure 
configuration used, cell seeding density, the density of cells at time of exposure, exposure 
duration, exposure media volume and culturewear used (with justifications for 
aforementioned chosen parameters where appropriate). Additionally, during suspension 
preparation (if applicable), determination of the DSE, optimization of the sonication step 
(both time and crDSE), and adequate characterization of the suspension properties should 
also be performed. The recoded dose should be standardized, but the important aspects 
include the concentration in terms of NM number and mass per surface area (NM/cm2), and 
any conditions that may modify the locally received dose. Modelling of the agglomeration 
and transport where possible would also be advantageous. Development of Graphical User 
Interfaces (GUIs) that can aid in determination of the local dose would be ideal, whereby 
experimental parameters are input, and a local dose estimated based upon these parameters 
and the suspension properties, for which a few different models already exist (Cohen et al., 
2008; Hinderliter et al., 2010; DeLoid et al., 2017). 
 
 
Other factors that can affect NM dose and toxicity 
Role of cell cycle and cell division on NM uptake 
Typical in vitro experiments are performed in cell populations in which individual cells 
progress independently through different phases of the cell cycle. In such conditions, 
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continuous exposure to NM leads first to linear uptake into cells, then at later stages the 
internalised NM load plateaus as an apparent saturation occurs (Salvati et al., 2011; Shapero 
et al., 2011; Kim et al., 2012).This saturation effect could be attributed to the NM depletion 
in the extracellular medium, saturation of cell / cell surface receptors, or competition 
between uptake and export or degradation of the internalised NMs, in addition to the effect 
of the cell division. When the cells divide the internalised NM burden is split among daughter 
cells, (Summers et al., 2011, 2013; Kim et al., 2012).  It is therefore important in this context 
to develop methods that are able to discriminate between these possibilities and to 
distinguish eventual NM export or degradation from simple dilution by cell division. As a 
consequence of cell division, after hours of uptake, individual cells within the same 
population may have varied amounts of internalised NMs (Kim et al., 2012; Summers et al., 
2013). Therefore, the internal dose is different and consequently different effects may be 
observed at single cell level in comparison to the average behaviour of the full population.   
 
Due to this heterogeneity, it has been suggested that the measurement of mean population 
response is somewhat inadequate for assessment of subtle cellular changes following 
treatment, such as NM internalisation (Manshian et al., 2015). Neighbouring cells have been 
seen to undergo different responses to NMs and cell averaging may mask subtle changes that 
occur in minority populations, an effect that is applicable across most fields of biology.  
Manshian et al showed the value of binning data to determine significant toxicity values in 
subsets of the population, rather than simply averaging cell values when estimating the safe 
concentrations of NMs (Manshian et al., 2015). They showed that sub-populations of cells 
undergo different effects following NM treatments, including a portion that undergo cyto-
protective effects and some that undergo cytotoxic effects.  This was masked by a net-zero 
overall change in the cell population measured as a whole. 
 
This all suggests that for quantitative uptake and toxicity studies the initial cell density and 
the effect of cell cycle should also be taken into account, as different starting conditions will 
lead to different distributions of the population among the individual phases of the cell cycle 
and this will lead ultimately to different uptake levels. On another level, it may be important 
in future to develop methods to distinguish and determine single cell uptake and NM impact 
in respect to full population behaviours.  Other approaches that have been developed are 
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the use of short pulses of exposure (10 minutes to 1-4 hrs), followed by longer observation 
times, in order to track movement of NMs inside cells, and to correlate localisation with 
observed effects (Wang, Bexiga, et al., 2013; Wang, Yu, et al., 2013; Guggenheim et al., 
2016).  While an analysis of methods for quantification of internalised NMs was beyond the 
scope, a summary of approaches is provided in the Supplementary Information. 
 
The bystander effect in toxicity studies 
Another factor to take into consideration is that of indirect effects due to the presence of 
NMs.  Many efforts so far have been focused in controlling NM uptake and defining the dose 
delivered intracellularly in order to obtain quantitative and reproducible accumulation and 
correlate the internalised dose with the eventual impacts observed. However, several studies 
report that NMs can also induce indirect effects by activation of signalling pathways which 
can propagate to neighbouring cells, even if these cells are not directly in contact with the 
NMs or indeed regardless of NM internalisation. NMs have been observed to confer the 
capacity to activate signalling pathways by the interaction of corona proteins with specific 
receptors at the cell surface or as a consequence of opsonisation and immune system 
activation (Fadeel and Garcia-Bennett, 2010; Marano et al., 2011; Boraschi, Costantino and 
Italiani, 2012; Ilinskaya and Dobrovolskaia, 2016; Pallardy, Turbica and Biola-Vidamment, 
2017). Such an effect has been reported, for instance, upon adsorption of fibrinogen to 5nm 
acetic acid capped gold NMs which led to the unfolding of fibrinogen and caused exposure of 
a cryptic epitope which interacts with MAC-1 receptor on macrophages, leading to activation 
of NFkB pathway (Deng et al., 2012; Marucco et al., 2014; Corbo et al., 2016).  Another 
example is the changes in conformation of the cytoskeletal protein tubulin in the presence of 
TiO2 NMs; tubulin carries out a host of different functions within cells and its conformational 
loss could therefore lead to wide scale disruption of cellular function (Gheshlaghi et al., 
2008). 
 
The signalling properties of NMs are also relevant to signalling across cell barriers. For 
instance, regardless of the capacity of a NM to physically cross cell barriers such as the BBB 
or the placenta, it has been observed that NMs can induce impact across these barriers in a 
paracrine fashion (Sood et al., 2011; Raghnaill et al., 2014) (Raghnaill et al., 2014). For 
example, paracrine signalling has been observed in the case of in vitro human blood brain 
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barrier (BBB) models exposed to NMs in the presence of astrocytes in the basal chamber 
(Raghnaill et al., 2014).  BBB endothelial cells exposed to PS NMs produced relatively low 
levels of cytokines; however, when astrocytes were added, anti-inflammatory signals were 
amplified. This also suggests that overall the impact observed in single cell culture systems 
may be different to that observed in co-culture models or in the presence of multiple cell 
types, where signalling across the different cell types can amplify and modulate the response 
due to exposure to NMs, leading to different outcomes.  All of these effects should be taken 
into consideration when assessing NM impact on cell functions. 
 
NM uptake under more physiological conditions 
Efforts to improve the physiological relevance of 2D culture, such as the ALI approach 
described above, can be further enhanced through, for example, direct measurement of the 
ALI delivered cellular dose which is possible by the addition of a Quartz Crystal Microbalance 
(QCM) within the system, underneath the exposed culture in mass deposited per area ng-
µg/cm2. This circumvents problems of modelling NM dose (such as in other exposure 
configurations), as the actual deposited dose is measured. This therefore provides 
experimental detail of delivered dose, which as discussed, is a necessity for meaningful 
comparison of toxicological study data which is important in all exposure scenarios.  Models 
of other exposure scenarios (i.e. through ingestion) such as gastrointestinal (GI) tract exist, 
that aim to either mimic the dynamic changing environment along the entire GI tract, or aim 
to model the translocation and uptake behaviour in intestinal epithelium models (Hedwig M 
Braakhuis et al., 2015; Lefebvre et al., 2015). These models consist of simple 2D models (such 
as the Caco-2 cell line) or more complex multicellular models that contain intestine microfold 
cells, however these intestinal models lack the mucus layer that is present in vivo and ex vivo 
or GIanimal models (Hedwig M Braakhuis et al., 2015; Lefebvre et al., 2015).  Although these 
types of 2D cell cultures clearly offer an invaluable tool for hazard characterization, it is 
generally recognized that they do not adequately represent the multicellular physiological 
environment in vivo (Smalley, Lioni and Herlyn, 2006; Braakhuis et al., 2015; Evans et al., 
2017). Multicellular functions and cellular interactions are lost when using simplified 2D 
culture systems which can lead to inaccuracies when assessing potential toxicities and 
ultimately lead to suboptimal translation to the situation in vivo (Smalley, Lioni and Herlyn, 
2006; Braakhuis et al., 2015; Henriksen-Lacey, Carregal-Romero and Liz-Marzán, 2016). With 
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the advent of new approaches (such as those used in IATAs) and multi-parametric and multi-
test scoring approaches of NM toxicity, some of the problems can be alleviated (Wiemann et 
al., 2016; Hansjosten et al., 2017). However, there is an interest in combining the 
aforementioned in vitro exposure models with 3D culture and co-culture models and the use 
of reconstructed tissues that can incorporate a wide range of physiological conditions more 
closely mimicking that of native tissue (Evans et al., 2017). 
 
3D cell culture models overcome some of the limitations of traditional 2D cell cultures by the 
introduction of cell-cell interactions, oxygen and nutrient gradients, and, importantly for 
nano-research, non-uniform NM dose through the 3D structure (Yoshii et al., 2011; Cui, 
Hartanto and Zhang, 2017; Evans et al., 2017). Spheroid culture models can be combined 
with an endothelial cell coating, such as that used by Ho et al to mimic the endothelium of 
blood vessels surrounding the tumour, which can be used to model extravasasion and 
penetration of NMs (Ho et al., 2012). A relatively new concept within is the development of 
even more complex co-culture spheroids, called ‘organoids’ which resemble miniature organs 
such as the kidney, liver and pancreas (Kermanizadeh et al., 2014; Broutier et al., 2016; 
Fatehullah, Tan and Barker, 2016; Henriksen-Lacey, Carregal-Romero and Liz-Marzán, 2016; 
Skardal, Shupe and Atala, 2016; Takasato et al., 2016). Reconstructed tissues can exhibit 
characteristics that are very similar to native tissue in terms of morphology (e.g. fully 
stratified tissue), differentiation markers (e.g. ciliated cells, presence of tight junctions) and 
functional activities (e.g. mucus secretion, specialized cell for trans-epithelial transport, cilia 
beating, cell communications). These features are important in cellular uptake of NMs and 
cell behaviour in response to NM exposure. Reconstructed tissue models can therefore be 
used in conjunction with the aforementioned exposure configurations to inform on the 
transport of NM through biological barriers, such as the skin, placenta, intestine and lungs 
(des Rieux et al., 2007; Vankoningsloo et al., 2010; Hedwig M Braakhuis et al., 2015; Lefebvre 
et al., 2015; Kooter et al., 2017; Vinardell et al., 2017). Reconstructed skin models have 
received the most attention currently in the field of NM safety assessment, due to the 
widespread use of NMs in sunscreans and cosmetics, leading to the availability of a variety of 
3D- reconstructed skin models, including but not limited to EpiSKIN and EpiDerm (Mathes, 
Ruffner and Graf-Hausner, 2014; Hayden et al., 2015; Kim et al., 2016; Wills et al., 2016; 
Evans et al., 2017; Hao et al., 2017; Vinardell et al., 2017). These models have been used in 
39 
 
conjunction with exposure to NMs such as MWCNTs and zinc oxides (ZnO) to determine the 
toxicity in these cell systems as opposed to dosing in standard 2D culture (Vankoningsloo et 
al., 2010; Vinardell et al., 2017). 
 
Co-culture, organoid and reconstructed tissue approaches can be employed in microfluidic 
devices, such as the tissue and organ/organoid-on-chip approaches, and these 3D in vitro 
methods have already proven useful for measuring the penetration and translocation of NMs 
(Huang et al., 2012; Albanese et al., 2013; Bryce et al., 2013; Bhatia and Ingber, 2014; Endes 
et al., 2014; Kang et al., 2016; Zervantonakis and Arvanitis, 2016). Future improvements to 
these microfluidic devices to include other dynamic processes such as perfusion and blood 
filtration, such as in the liver and kidneys, could improve further on the translation between 
these devices and the in vivo behaviour of NMs following exposure (Rennert et al., 2015; 
Wilmer et al., 2016). Another advantage of using reconstructed tissues is the possibility to 
mimic more realistic exposure scenarios in terms of NM presentation and dosimetry; 
although it is likely that the modelling of these NM transport processes will be more difficult 
than in static cultures. Indeed, some reconstructed human tissue (e.g. respiratory tract or 
epidermis) are cultivated in the ALI cell culture systems previously mentioned, allowing 
direct aerosol exposure systems for respiratory studies for both dispersed and dry nano-
powders, or commercial formulations for cutaneous studies, thereby avoiding physical and 
chemical interactions that can occur in culture media (Fierz et al., 2011; Mülhopt et al., 2016; 
Kooter et al., 2017). The dose is usually expressed as mass deposition per culture surface 
(µg/cm2) but there are no standard protocols so far for the NM concentration range to test. 
For chemical regulatory toxicity testing, the OECD guidelines for cutaneous irritation 
assessment (OECD TG 439) recommend to uniformly cover the reconstructed epidermis 
surface with the test chemical and controls with a minimum dose of 25 μL/cm2 or 25 
mg/cm2.  Therefore, the physico-chemical parameters that affect NM deposition and cellular 
uptake and transport may have to been reconsidered in ALI tissue cultures. 
 
Another interesting in vitro model that could be exploited for nanosafety studies is the use of 
precision cut tissue slices (PCTS). PCTS have already been established for drug toxicity 
testing: they allow reduced use of animals while testing compounds but maintain the cell 
complexity and architecture of a real tissue (Graaf, Groothuis and Olinga, 2007; de Graaf et 
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al., 2010). The use of PCTS for nanosafety studies has not been fully exploited yet: while 
PCTS could bring several advantages because of the use of real tissue, particular care should 
be taken to develop methods to add the NMs to the PCTS resembling the way they would 
reach that particular organ in vivo (Hirn et al., 2014; Merz et al., 2017), including any 
evolution of adsorbed biomolecules that would be associated. 
 
Conclusions 
This review summarised the modes of exposure reported in NM toxicity studies, and the 
need for standardization and complete reporting of exposure conditions and experimental 
metadata to allow cross-comparability between studies.  In particular the critical definition of 
dose in cell culture assay and tissue culture has been discussed and emphasized. 
Experimental conditions were highlighted that affect the local dose received by cultured cells 
in terms of number of NMs per cell, highlighting important considerations when conducting 
NM studies and indicating the minimal information to be included within studies to enable 
correlation of cellular received dose with observed toxicological response. The current state 
of the art in experimental settings and reporting in published nanotoxicity studies is often 
insufficient to derive the local dose and hence leaves room for discrepancies in the 
interpretation of dose-response relations. Standardized protocols for defined exposure are 
desirable, such that a higher level of comparability is achieved. 
 
Therefore, to summarise there is a host of different options in terms of exposure 
configurations for NM investigations. The choice of which presentation method to use will 
depend on some key parameters namely: the type and form of NM that is to be investigated, 
the type of system to be modelled (i.e., ALI for toxicity testing of inhaled particles), and the 
parameters that need to be controlled for, such as NM agglomeration or pre-defined (or 
directly measured) NM dose. Each exposure setup offers different advantages and 
disadvantages summarised in Figure 3 and each allow precise control over different 
outcomes, or encompass simplified or more complex exposure methods. Regardless of the 
choice of exposure model, the information between different exposures must be reliable and 
reported in such a way that allows comparisons between different experimental designs. 
Therefore, we suggest the minimal required information for each exposure configuration as 
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presented below and summarised in Table 2. Our overall recommendations, regardless of the 
exposure configuration are as follows (see also SI for the brief protocol): 
1. Dispersion information 
a. Calibration of sonicator and reporting of the critical DSE (optimized for the 
material to achieve suspension of the smallest possible aggregates) 
b. Concentration of the original dispersion 
c. Characterizations (minimum of TEM and DLS or DCS pre and post incubation 
in culture medium) 
d. Potential agglomeration over time and the effective density of agglomerates 
e. Dissolution in media over experimental time-course 
f. Corona characterization of NM in both conditioned and unconditioned 
media. We recommend the protocol described in (Albanese et al., 2014) 
2. Cell information 
a. Seeding density 
b. Density at exposure 
c. Cell size (area) 
3. Vessel information 
a. Well plate format (6, 12, 24, 96 etc) and exact area of plate 
b. Shape of container bottom (round, flat etc) 
c. Volume and height of media used per well 
d. Material of container and binding potential 
4. NM exposure dose 
a. Time length of incubation 
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b. Number and frequency of doses (single or multiple) 
c. Total administered dose 
d. Calculated local dose (particle number per area) and surface area of NM, 
based upon existing models that incorporate estimations of diffusion, 
sedimentation, dissolution and agglomeration if applicable (upright and 
submerged cultures). 
These recommendations are based on the previously discussed issues surrounding 
difficulties in obtaining accurate comparisons between performed studies. By documenting 
all of the available and appropriate metadata, even if the local dose reported between 
papers is in a slightly different form, the availability of all the other exposure parameters 
allows readers to recalculate various aspects of the experimental set up and dynamics, in 
addition to improving consistency between experiments and therefore increasing result 
quality and comparability. The work performed within the QualityNano infrastructure has 
allowed development of robust SOPs capturing these factors: coupled with appropriate 
training of the researcher performing the tests, the developed SOPs allowed generation of 
highly reproducible data on NM uptake and cytotoxicity in independent laboratories. The 
SOPs (characterisation by DLS and DCS, quantification of cellular uptake of NMs by flow 
cytometry and cytotoxicity determined by the MTS assay, and the interlaboratory 
comparisons undertaken on them) are described in detail in articles included in this special 
issue (Langevin et al. 2017; Salvati et al. 2017). 
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Particle 
Size (nm) 
Preparation Characterization 
Cell 
density 
Exp 
Timing (h) 
NM 
concentration 
Vol of 
exposure 
media 
Area 
(cm²) 
NM Cellular 
Dose 
Ref 
3-104 
Probe sonicated 
(750w, 20kHz, 
29%)  10-15 s (x2) 
DLS, TEM, BET 
100000 until 70-80% 
confluency 
24 2-100 µg/mL Not stated 9.6/3.9/1.9 Not known Han 2012 
15 
Probe sonicated 3 
min. Stored at -
20°C/ Son. 3x20 s 
(60w) 
DLS, zeta potential 
10000 
cell/cm
2 
72 h 24 5-160 µg/cm
2 Not stated 3.9 Not known Hussain 2009 
20 Milling 
DLS, TEM, (XRD, BET 
previously) 
16000 
cell/cm
2 
~15 h 24 150-3000 µg/mL Not stated 9.6/0.32 Not known Tedja 2012 
5 Sonicated 5 min 
TEM, XRD, PCS, 
ICP-AES 
3000 cell/well 24/48 3-600 µg/mL 200 µL 0.32 
Could be 
calculated 
Jin 2008 
400 
(measured 
by DLS) 
Probe 10 min (10 x 
1 min) 60w with ice 
water bath 
DLS, Zeta potential, PDI, 
TEM 
10000-600000 cell/well 24 
5-800 µg/mL 
1-160 µg/cm
2 
Not stated 25/0.32 Not known Hanot Roy, 2016 
Table 1. Summary of the experimental information gathered from 5 research articles aimed at assessing TiO2 uptake in cell lines. Taken from Han 2012, 
Hussain 2009, Tedja 2012 and Jin 2008, Hanot-Roy, 2016. 
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 Preparation/ 
dispersion 
Submerged cell 
culture 
Inverted cell 
culture 
Air liquid presentation 
Surface 
presentation 
Parameter 
obtained in 
method 
Distributed 
sonication 
energy 
Delivery by 
sedimentation and 
diffusion 
 
Buoyant NM 
exposure 
 
Delivered dose determination 
using QCM 
Dynamic delivery 
Bypasses agglomeration 
NM dose known 
Bypasses 
agglomeration 
To be 
reported 
Characterization 
(size, charge) 
Agglomeration 
potential 
(modelled, 
estimated or 
measured) 
 
Calculation of dose delivered (using 
model e.g. DeLoid 2017) 
Necessary information to calculate dose 
(media height / total volume / well plate 
used, area) 
Duration of exposure 
Number of cells at plating and exposure 
/ size of cells 
Make and type of culturewear 
 
Report the recorded dose 
(QCM) 
Cell number at plating and 
exposure 
Information on culturewear 
(area of exposure) and 
conditions (make of transwell 
insert, membrane type) 
Exposure duration 
Report dose 
fabricated onto well 
Cell number at 
plating and 
exposure 
Exposure duration 
Well type (make and 
size / area) 
Table 2. Summary of how preparation and different NM exposure systems offer specific parameters and the different minimal information that needs to be 
reported in each case to ensure comparability of data generated. 
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Figure 1. The dosing of cells with NMs in an upright (standard) configuration. The NMs must first be 
appropriately dispersed, diluted in the cell medium and then applied to cells. A variety of factors will 
impact on the transport rate of NMs to cells and therefore the delivered dose, including: 1) diffusion, 
2) Sedimentation, 3) dissolution in media and 4) agglomeration state (both homoagglomeration with 
other particles and potentially heteroagglomeration with the walls of the exposure chamber). 
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Figure 2. Depiction of receptor mediated endocytosis (adapted from (Banerjee, Berzhkovskii and 
Nossal, 2014). NMs coated in biomolecules come into contact with cell surface receptors of which 
there are a finite number of on the cell surface. Interactions between an NM surface protein and a 
receptor at the cell surface result in the formation of a NM-receptor complex. This complex can then 
recruit more cargo, coat proteins and adaptor molecules, increasing in size. These are then ‘pinched 
off’ to form intracellular vesicles that can transport within the cell through the endolysosomal sys-
tem, where these NMs remain unless they manage to illicit endolysosomal escape. 
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Figure 3. Comparison of the available methods for exposure of NM in adherent cell cultures. Methods include the described standard upright exposure 
configurations, NM surface presentation whereby NMs are fixed at the well surface and cells plated above the NM layer of known density. The inverted cul-
ture system is ideal for buoyant NMs, and the ALI system allows modelling of airborne exposure via specialised chambers. 3D spheroid/organoid generation 
is also depicted, which allows for mimicking of 3D culture systems resembling tumour delivery or complex organ structure, respectively. Some of the ad-
vantages and disadvantages or each approach are stated. 
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Figure 4. Depiction of the sedimentation and diffusion of NMs. Sedimentation varies with NM diam-
eter and density and media density (drag force Fd and buoyance Fb opposite gravitational force Fg).The 
covered distance ξs is determined by the sedimentation velocity vs and the time t. Diffusion depends 
upon the height of the media and the NM properties such as density and size. The covered distance 
ξd is proportional to the square root of Diffusion D and time t. 
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Figure 5. Comparison of sedimentation of NMs in different submerged culture formats 
A) Fluorescent overview images of fluorescent PS-COOH NMs for 96 well plates, 8 well slides, petri-
dish and channel slides (left: not rinsed right: after rinsing). B) Model of experimental data of rate of 
sedimentation of fibres as a function of the shape of the respective container. Open container (96 
well plate, 8 well, petri dish) show meniscus effects and hence a inhomogeneous NM surface 
distribution, whereas closed containers (channel) exhibit a homogenous NM distribution. 
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Figure 6. Schematic representation of the NM surface preparation: A. NMs are injected and sedi-
mented inside a µ-channel in order to avoid meniscus effects. B, C. Homogeneous distributions of 
NMs (B) and cells (C) are achieved all along the channel. Scale bars correspond to 50 µm. D, E, F. NM 
surface density with varying NM concentration in solution (D) 100 pM, (E) 25 pM and (F) 12.5 pM. 
Scale bars correspond to 5 µm. (Reprint from (Alberola and Rädler, 2009)). 
 
 
 
 
